title: Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
authors.affiliation: Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK. christopherboos@hotmail.com
authors.forename: C J
authors.initials: CJ
authors.lastname: Boos
authors.forename: G Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology*; D012084:Renin-Angiotensin System
chemical_list: D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents